Characteristics and therapy of premenopausal patients with early-onset breast cancer in Germany

Archives of Gynecology and Obstetrics

Volumn 286, Issue 2, 2012, Pages 489-493

  Banz Jansen, Constanze ^a   Heinrichs, Alessa ^a   Hedderich, Marianne ^a   Waldmann, Annika ^b   Dittmer, Christine ^a   Wedel, Berit ^a   Mebes, Imke ^a   Diedrich, Klaus ^a   Fischer, Dorothea ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Breast cancer; Premenopausal patients; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GONADORELIN DERIVATIVE; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADULT; AGE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; EARLY CANCER; FEMALE; GERMANY; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PREMENOPAUSE; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; GERMANY; HUMANS; LYMPH NODES; MASTECTOMY; MIDDLE AGED; NEOPLASM GRADING; PREMENOPAUSE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84864436179     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2291-9     Document Type: Article

References (17)

1. Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 107:427-430
2. Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A (2009) Trends in hormone therapy and breast cancer incidence - results from the German Network of Cancer Registries. Pathobiology 76:90-97
3. DeMichele A, Putt M, Zhang Y, Glick JH, Norman S (2003) Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97:2150-2159
4. Kosiak B, Sangl J, Correa-de-Araujo R (2006) Quality of health care: what do we know? Womens health Issues 16:89-99
5. Waldmann A, Pritzkuleit R, Raspe H, Katalinic A (2008) Guideline-compatible treatment of breast cancer patients. Dtsch Ärztebl Int 105(18):337-343
6. (2009) Disease-management-programme in Nordrhein Qualitätsbericht 2009. http://www.kvno.de/downloads/quali/qualbe-dmp09.pdf
7. Robles-Castillo J, Ruvalcaba-Limon E, Maffuz A, Rodriguez-Cuevas S (2011) Breast cancer in Mexican women under 40. Ginecol Obstet Mex 79(8):482-488
8. Kheirelseid EH, Boggs JM, Curran C, Glynn RW, Dooley C, Sweeney KJ, Kerin MJ (2011) Younger age as a prognostic indicator in breast cancer: a cohort study. BMC Cancer 11:283
9. Tarone RE (2006) Breast cancer trends among young women in the United States. Epidemiology 17(5):588-590
10. Gonzales-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, Theriault R, Booser D, Buzdar AU, Hortobagyi GN, Arun B (2005) Women age
11. Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schäfer P, Sappino AP, Kurtz J, Neyroud-caspar I, Bouchardy C (2005) Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 41(10):1446-1452
12. Love RR, Duc NB, Dinh NV, Quy TT, Xin Y, Havighurst TC (2002) Young age as an adverse prognostic factor in premenopausal women with operable breast cancer. Clin Breast cancer 2(4):294-298
13. Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, Al Malik O, Alshabanah M, Ezzat A, Al-Tweigeri T (2007) Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer 7:222
14. Loibl S, Amant F, Kaufmann M, Ring A, Han S, Giermek J, Fehm T, Bontenbal M, Heinrigs M, Lenhard M, Scherr I, Mehta K, von Minckwitz G (2010) Patients with breast cancer during pregnancy-results from a prospective and retrospective registry (GBG20/BIG02-03). Cancer Res 70(24):S6-S12
15. El-Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, Geara FB, Shamseddine AI (2006) Effects of young age at presentation on survival in breast cancer. BMC Cancer 6:194
16. O'Shaughnessy J, Osborne C, Pippen JE, Yoffe M, Patt D, Rocha C, Koo IC, Sherman BM, Bradley C (2011) Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med 364(3):205-214
17. de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ (2006) Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer Studies. Eur J Cancer 42(3):351-356